Scotland says no to second Alzheimer's drug, donanemab
|
Donanemab – one of the first drugs to slow down
early-stage Alzheimer's disease – will not be available on the NHS in Scotland. |
Ireland good for fintech but geo-political tensions present risks – survey
FPAI's inaugural Irish Fintech Survey has found Ireland still good base for fintech business but geo-political tensions could be a challenge for ... View article...